Avoro Capital Advisors Reduces Its Stake in MRUS ($MRUS)
Avoro Capital Advisors no longer holds any shares of MRUS after selling its entire position.
Key Points
- Avoro Capital Advisors sold its entire stake of 3,542,500 shares in MRUS, as reported in its latest 13F filing.
- Several other institutional investors, including Eversource Wealth Advisors and XTX Topco Ltd, also completely exited their MRUS positions.
- Multiple analysts, including Leerink Partners and Guggenheim, downgraded MRUS to a hold rating in late 2025.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Avoro Capital Advisors has completely sold out of its position in MRUS, as shown in its recent filing with the SEC on February 17, 2026. The fund offloaded all 3,542,500 shares it previously held, marking a 100% reduction in its stake.
What Changed in Avoro Capital Advisors' MRUS Position
Avoro Capital Advisors reduced its holdings in MRUS by 3,542,500 shares, leaving it with no shares as of the filing. This move represents a complete exit from its prior position. Previously, the firm held 3,542,500 shares, indicating a full divestment.
Other Institutional Activity in MRUS
Several other institutional investors also sold out their positions in MRUS. Eversource Wealth Advisors, LLC reduced its holdings by 53 shares, ending with none. XTX Topco Ltd divested 26,768 shares, also exiting completely. Similarly, IFP Advisors, Inc, Farther Finance Advisors, LLC, NTV Asset Management LLC, and Brooklyn Investment Group each sold all their shares in MRUS, with reductions ranging from 3 to 2,452 shares.
Insider Buying and Selling at MRUS
Genmab A/S made significant insider purchases of MRUS shares in late December 2025. On December 29, Genmab A/S bought 76,920,005 shares at an average price of $97 per share. Earlier, on December 26, the company also acquired 2,978 shares and 142,610 shares, respectively, at the same price.
Analysts Set New Price Targets
In late 2025, several analysts downgraded MRUS to a hold rating. On October 6, 2025, Leerink Partners downgraded the stock, setting a price target of $97. Similarly, on September 30, Guggenheim, Canaccord Genuity, UBS, LifeSci Capital, Barclays, and HC Wainwright & Co. all issued hold ratings with the same target price. Truist Securities also downgraded the stock to hold on September 29.
Bottom Line
Avoro Capital Advisors' decision to sell all its MRUS shares is part of a broader trend among institutional investors, many of whom also exited their positions. The recent analyst downgrades to hold ratings reflect cautious sentiment around the stock. Investors will keep an eye on MRUS for any future developments, remembering that 13F filings are backward-looking and may not reflect current positions.
Get MRUS alerts
New 13F filings, insider trades, and analyst moves on $MRUS, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.